Canada Canntab Therapeutics enters the Nova Scotia cannabis marketplace Cannabinoid tablet supplier expands its Canadian distribution network Rowan DunneAugust 22, 2022
Canada PharmAla Biotech becomes first public company producing GMP MDMA Biotechnology organization will also supply LaNeo product to Australian research institute for clinical trial Rowan DunneAugust 22, 2022
Research ‘Hallucinogen’ use continues to rise: Columbia University New research estimates that over 5.5 million American adults used psychoactive substances in 2019 Rowan DunneAugust 22, 2022
Psychedelics Phillips Lytle announces the inception of its Psychedelic & Mental Health Therapies Practice New York law firm forms multidisciplinary association intended to serve the psychedelic industry Rowan DunneAugust 19, 2022
Research Better sleep quality calls for better data: Yam and Goettling Better follow up is also a necessity, and wearable sleep trackers are only the beginning Rowan DunneAugust 19, 2022
Cannabis Tyson 2.0 and Verano collaborate to launch Ric Flair Drip Cannabis line New flower, edibles, vapes and pre-rolls set for delivery across Verano's American distribution network Rowan DunneAugust 18, 2022
Cannabis Jointly releases data showcasing cannabis health benefits New statistics come from over 200,000 unique experiences cannabis users have recorded on the company platform Rowan DunneAugust 18, 2022
Cannabis Cybin receives Schedule I DEA license for CYB003 trial New license is the final required step before administering doses to study participants Rowan DunneAugust 17, 2022
Business Benzinga Cannabis Capital Conference makes its way to Chicago Prominent speaker lineup promised for 'the largest cannabis investing and finance event' this September Rowan DunneAugust 17, 2022
Stock News Reunion Neuroscience starts trading on the TSX Reunion still holds 21.84% interest in Field Trip Health & Wellness Rowan DunneAugust 17, 2022